4 largest pharmaceutical firms witness 418 percent increase in sales during decade

Published: 2012-05-07 06:59:00

Updated: 2012-05-07 06:59:00

Korea’s ‘Big Four’ drug makers, such as Dong-A, Daewoong, Green Cross and Yuhan, have seen a whopping sales increase of 418 percent over the past 10 years, according to a report compiled by Yakup.com, a pharmaceutical information company.

The report showed that Green Cross posted 698.8 billion...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK